Table 2 Drug related problems in type 2 diabetes patients with hypertension (n = 387)
Code | Problems* | Number of problem (Percentage, %) |
|---|---|---|
P1 | Adverse reactions | 25 (6.5) |
P1.1 | Side effects suffered (non-allergic) | 25 (6.5) |
P2 | Drug choice problems | 87 (22.5) |
P2.1 | Inappropriate drug (not most appropriate for indication) | 34 (8.8) |
P2.2 | Inappropriate drug form (not most appropriate for indication) | 4 (1.0) |
P2.3 | Inappropriate duplication of therapeutic group or active ingredient | 4 (1.0) |
P2.4 | Contraindication for drug | 29 (7.5) |
P2.5 | No clear indication for drug use | 1 (0.3) |
P2.6 | No drug but clear indication | 15 (3.9) |
P3 | Dosing problems | 62 (16.0) |
P3.1 | Drug dose too low or dosage regime not frequent enough | 5 (1.3) |
P3.2 | Drug dose too high or dosage regime too frequent | 44 (11.3) |
P3.3 | Duration of treatment too short | 8 (2.1) |
P3.4 | Duration of treatment too long | 5 (1.3) |
P4 | Drug use problems | 50 (12.9) |
P4.1 | Drug not taken/administered at all | 50 (12.9) |
P5 | Interactions | 63 (16.3) |
P5.1 | Potential interaction | 63 (16.3) |
P6 | Others | 100 (25.8) |
P6.1 | Patient dissatisfied with therapy despite taking drug(s) correctly | 5 (1.3) |
P6.2 | Insufficient awareness of health and diseases (possibly leading to future problems) | 90 (23.2) |
P6.4 | Therapy failure (reason unknown) | 5 (1.3) |